Profit: Gene therapy for intervertebral disc degeneration (Q3301670): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr: Adding French translations) |
(Changed label, description and/or aliases in nl: Adding Dutch translations) |
||
| label / nl | label / nl | ||
Winst: Gentherapie voor intervertebrale schijfdegeneratie | |||
Revision as of 10:48, 19 December 2021
Project Q3301670 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Gene therapy for intervertebral disc degeneration |
Project Q3301670 in Germany |
Statements
999,126.65 Euro
0 references
1,248,908.31 Euro
0 references
80.0 percent
0 references
1 December 2019
0 references
30 June 2022
0 references
Genequine Biotherapeutics GmbH
0 references
52°5'24.72"N, 13°10'27.08"E
0 references
Luckenwalde, Stadt
0 references
Identifiers
DE_TEMPORARY_4472
0 references